Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yang Qing Chen Fei Granules, Bao Jin Chen Fei Granules, and Jin Shui Chen Fei Granules are a series of Traditional Chinese Medicine (TCM) compound formulations developed by the Henan University of Traditional Chinese Medicine specifically for the treatment of Coal Worker's Pneumoconiosis (CWP). These medicines are administered based on TCM syndrome differentiation: **Yang Qing Chen Fei Granules** are indicated for the syndrome of yin deficiency and heat-dryness; **Bao Jin Chen Fei Granules** are used for pulmonary qi deficiency; and **Jin Shui Chen Fei Granules** are applied for the deficiency of pulmonary and renal qi. The granules are manufactured by Sichuan Neo-Green Pharmaceutical Technology Development and are being evaluated in multicenter clinical trials to provide evidence for their efficacy in improving lung function and quality of life in CWP patients when used alongside standard symptomatic care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yang Qing Chen Fei Granules + Bao Jin Chen Fei Granules + Jin Shui Chen Fei Granules.